Notwithstanding the caveats inherently associated with recombination efficiencies at lox P sites, our results are indicative of a critical extra-neuronal requirement for the SMN protein and argue for a systemic restoration of the protein as a means to a truly effective treatment for severe spinal muscular atrophy. Here, SMN2 is linked to spinal muscular atrophy.